Making Waves, Albeit Small Ones, in Orthopedics
Fulfilling its promise that it would use money raised in last year's IPO to begin an active acquisition campaign, DePuy Inc. announced this month that it would acquire 90% of the leading French implant company, Landanger-Camus [See Deal].
You may also be interested in...
In December, a California federal court ordered the US Environmental Protection Agency to amend its TSCA Chemical Data Reporting rule to address asbestos information-gathering “loopholes,” including a current exemption for asbestos that occurs as an impurity in raw materials such as cosmetic talc.
L'Aquila, Italy-based Dante Laboratories company announced a £30m investment in global surveillance of new variants of the SARS-CoV-2 virus. CEO Andrea Riposat discussed the purchase.
‘Everything is on the table,’ including invoking the Defense Production Act, White House COVID Coordinator Zients notes. Results of J&J’s Phase III vaccine trial expected ‘within next few days to a week.’